Biogen Inc (NASDAQ:BIIB)

429.87
Delayed Data
As of Mar 27
 +0.94 / +0.22%
Today’s Change
272.02
Today|||52-Week Range
480.18
+26.64%
Year-to-Date

Today’s Trading

Previous close428.93
Today’s open430.12
Day’s range429.36 - 436.67
Volume1,859,181
Average volume (3 months)1,900,780
Market cap$100.9B
Dividend yield--
Data as of 3:59pm ET, 03/27/2015

Growth & Valuation

Earnings growth (last year)+58.39%
Earnings growth (this year)+23.06%
Earnings growth (next 5 years)+19.10%
Revenue growth (last year)+39.61%
P/E ratio34.7
Price/Sales8.27
Price/Book9.33

Competitors

 Today’s
change
Today’s
% change
AMGNAmgen+2.04+1.27%
GILDGilead Sciences-0.08-0.07%
BAXBaxter International...+0.53+0.78%
JUNOJuno Therapeutics In...+3.17+5.93%
Data as of 4:14pm ET, 03/27/2015

Financials

Next reporting dateApril 23, 2015
EPS forecast (this quarter)$3.93
Annual revenue (last year)$9.7B
Annual profit (last year)$2.9B
Net profit margin30.27%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
George A. Scangos
Chief Financial Officer &
Executive Vice President
Paul J. Clancy
Corporate headquarters
Weston, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account